Can a Four-Drug cocktail shrink Hard-to-Treat lung tumors?
Disease control
Completed
This phase 2 trial tests whether adding lenvatinib to a standard chemotherapy-plus-immunotherapy regimen can shrink tumors in people with advanced non-squamous non-small cell lung cancer that has a specific EGFR mutation. Participants will receive lenvatinib capsules daily along …
Phase: PHASE2 • Sponsor: Juntendo University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC